{"text": ["Citron's", "Left", "reiterates", "belief", "AbbVie", "shares", "will", "fall", "sharply"], "created_at": "2018-07-24 21:16:41"}
{"text": ["AbbVie", "prices", "new", "endometriosis", "drug", "at", "$10,000", "a", "year"], "created_at": "2018-07-24 17:46:16"}
{"text": ["Is", "a", "Beat", "in", "the", "Cards", "for", "AbbVie", "(ABBV)", "in", "Q2", "Earnings?"], "created_at": "2018-07-24 17:11:53"}
{"text": ["Is", "a", "Beat", "in", "the", "Cards", "for", "AbbVie", "(ABBV)", "in", "Q2", "Earnings?"], "created_at": "2018-07-24 17:11:53"}
{"text": ["Merck", "(MRK)", "Q2", "Earnings", "Coming", "Up:", "What's", "in", "the", "Cards?"], "created_at": "2018-07-24 17:10:51"}
{"text": ["Merck", "(MRK)", "Q2", "Earnings", "Coming", "Up:", "What's", "in", "the", "Cards?"], "created_at": "2018-07-24 17:10:51"}
{"text": ["Merck", "(MRK)", "Q2", "Earnings", "Coming", "Up:", "What&apos;s", "in", "the", "Cards?"], "created_at": "2018-07-24 15:24:03"}
{"text": ["AbbVie", "Wins", "U.S.", "Approval", "for", "Endometriosis", "Pain", "Treatment"], "created_at": "2018-07-24 15:20:44"}
{"text": ["AbbVie", "Gets", "Approval", "for", "Endometriosis", "Pain", "Treatment"], "created_at": "2018-07-24 15:20:44"}
{"text": ["AbbVie", "Gets", "OK", "for", "Potential", "Blockbuster", "Endometriosis", "Treatment"], "created_at": "2018-07-24 15:20:44"}
{"text": ["Is", "a", "Beat", "in", "the", "Cards", "for", "AbbVie", "(ABBV)", "in", "Q2", "Earnings?"], "created_at": "2018-07-24 14:56:02"}
{"text": ["What's", "in", "Store", "for", "Cardinal", "Health", "(CAH)", "in", "Q4", "Earnings?"], "created_at": "2018-07-24 13:09:19"}
{"text": ["What's", "in", "Store", "for", "Cardinal", "Health", "(CAH)", "in", "Q4", "Earnings?"], "created_at": "2018-07-24 13:09:19"}
{"text": ["AbbVie", "wins", "FDA", "approval", "for", "oral", "treatment", "for", "endometriosis", "pain"], "created_at": "2018-07-24 12:53:00"}
{"text": ["Eli", "Lilly", "Surpasses", "Estimates,", "Reports", "Growth", "in", "Q2", "2018"], "created_at": "2018-07-24 12:52:07"}
{"text": ["AbbVie", "Receives", "U.S.", "FDA", "Approval", "of", "ORILISSA\u2122", "(elagolix)", "for", "the", "Management", "of", "Moderate", "to", "Severe", "Pain", "Associated", "with", "Endometriosis"], "created_at": "2018-07-24 12:30:00"}
{"text": ["What", "to", "Expect", "When", "AbbVie", "Reports", "Q2", "Earnings"], "created_at": "2018-07-24 12:07:58"}
{"text": ["What", "to", "Expect", "When", "AbbVie", "Reports", "Q2", "Earnings"], "created_at": "2018-07-24 12:07:58"}
{"text": ["What&apos;s", "in", "Store", "for", "Cardinal", "Health", "(CAH)", "in", "Q4", "Earnings?"], "created_at": "2018-07-24 11:58:11"}
{"text": ["J&J\u2019s", "Oncology", "Franchise", "Saw", "42.2%", "Growth", "in", "Q2", "2018"], "created_at": "2018-07-24 11:31:41"}
{"text": ["What", "to", "Expect", "When", "AbbVie", "Reports", "Q2", "Earnings"], "created_at": "2018-07-24 10:32:00"}
{"text": ["Validea", "John", "Neff", "Strategy", "Daily", "Upgrade", "Report", "-", "7/24/2018"], "created_at": "2018-07-24 09:06:24"}
{"text": ["Validea", "John", "Neff", "Strategy", "Daily", "Upgrade", "Report", "-", "7/24/2018"], "created_at": "2018-07-24 09:06:24"}
{"text": ["AbbVie", "Reports", "FDA", "Approval", "Of", "ORILISSA", "-", "Quick", "Facts"], "created_at": "2018-07-24 08:40:00"}
{"text": ["AbbVie", "Reports", "FDA", "Approval", "Of", "ORILISSA", "-", "Quick", "Facts"], "created_at": "2018-07-24 08:40:00"}
{"text": ["What\u2019s", "Next", "for", "Pfizer", "Stock", "After", "Being", "Called", "Out", "by", "President", "Trump"], "created_at": "2018-07-24 02:07:19"}
{"text": ["What\u2019s", "Next", "for", "Pfizer", "Stock", "After", "Being", "Called", "Out", "by", "President", "Trump"], "created_at": "2018-07-24 02:07:19"}
{"text": ["Will", "Strong", "HIV", "Sales", "Fuel", "Gilead", "(GILD)", "In", "Q2", "Earnings?"], "created_at": "2018-07-24 00:07:12"}
{"text": ["Will", "Strong", "HIV", "Sales", "Fuel", "Gilead", "(GILD)", "In", "Q2", "Earnings?"], "created_at": "2018-07-24 00:07:12"}
